Logo image of ORPH

ORPHAZYME A/S - ADR (ORPH) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:ORPH - ADR

0.87
-0.02 (-2.25%)
Last: 3/30/2022, 9:50:21 PM
0.8002
-0.07 (-8.02%)
After Hours: 3/30/2022, 9:50:21 PM
Buy % Consensus

38

ChartMill assigns a Buy % Consensus number of 38% to ORPH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 15.81. This target is 1717.72% above the current price.
ORPH was analyzed by 9 analysts. The buy percentage consensus is at 38. So analysts seem to be rather negative about ORPH.
In the previous month the buy percentage consensus was at a similar level.
ORPH was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

ORPH Historical Analyst RatingsORPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -51 -46 -41 -36 -31 -26 -21 -16 -11 -6 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.8715.6615.8115.8116.28 - 1,699.90% 1,717.72% 1,717.72% 1,771.18%

Related screens

ORPH Current Analyst RatingORPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

ORPHAZYME A/S - ADR / ORPH FAQ

What do analysts expect the price target to be for ORPHAZYME A/S - ADR (ORPH)?

9 analysts have analysed ORPH and the average price target is 15.81 null. This implies a price increase of 1717.72% is expected in the next year compared to the current price of 0.87.


What is the consensus rating for ORPH stock?

The consensus rating for ORPHAZYME A/S - ADR (ORPH) is 37.7778 / 100 . This indicates that analysts generally have a negative outlook on the stock.


What is the number of analysts for ORPH stock?

The number of analysts covering ORPHAZYME A/S - ADR (ORPH) is 9.